Is there a place for chemo- and immunotherapy combination in patients with high PD-L1 expression?
Dr. K. Cuppens, Jessaziekenhuis, Hasselt
Prof. Dr. K. Vermaelen, Universitair Ziekenhuis Gent
Dr. B. Forier, Universitair Ziekenhuis Leuven
Janssen-Cilag NV 2021. This site is published by Janssen-Cilag NV which is solely responsible for its content. It is intended for Healthcare professionals in Belgium and Luxembourg.